In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...

IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...

Molecular and genetic testing has become a game-changer in brain tumor care - shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these ...

El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...

NYU Langone’s Advanced Rodent Transgenics Laboratory assists researchers in generating mutant mice for experimental use.